GALE Galenica AG

Galenica successfully places a bond of over CHF 100 million

Galenica AG / Key word(s): Bond
Galenica successfully places a bond of over CHF 100 million

16.04.2024 / 18:05 CET/CEST

Press release

Today, Galenica successfully placed a fixed rate bond of over CHF 100 million.

The bond has a term of 7 years and an annual coupon of 1.65%. The proceeds from the transaction will be used for general corporate purposes. With this new bond, Galenica is reducing its short-term financial liabilities and securing its long-term financing. The term until 2031 ideally complements the terms of the outstanding bonds from 2026 (CHF 180 million, coupon 1.0%) and 2029 (CHF 240 million, coupon 2.35%).   

 

UBS and Zürcher Kantonalbank are joint lead manager for this issue. An application for admission to trading on the SIX Swiss Exchange for the bond is being made.

Dates for the diary

23 May 2024 Galenica Group sales update
6 August 2024   Galenica Group half-year results 2024
24 October 2024 Galenica Group sales update

 

For further information, please contact:

 

Media Relations:
E-Mail:
Tel. 7		 Investor Relations:
E-Mail:
Tel. 1

Welcome to the Galenica network!
Our ambition is to meet the needs of patients and customers in the Swiss healthcare market in a seamless, efficient and personalised way. To achieve this, we operate the Galenica network with over 20 Business Units, the strongest partners in the Swiss healthcare market. We offer fully integrated solutions both for customers and patients as well as for pharmacies, drugstores, medical practices, hospitals, retirement and nursing homes, home care providers, wholesalers, pharmaceutical companies, health insurance funds and other partners.
Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information concerning Galenica can be found at .


End of Media Release
Language: English
Company: Galenica AG
Untermattweg 8
3027 Bern
Switzerland
Phone: 11
E-mail:
Internet:
ISIN: CH0360674466
Listed: SIX Swiss Exchange
EQS News ID: 1881579

 
End of News EQS News Service

1881579  16.04.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1881579&application_name=news&site_id=research_pool
EN
16/04/2024

Underlying

GALEGalenica AG

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Galenica AG

Free Trial
GALE GALENICA AG

Galenica AG: 1 director

A director at Galenica AG sold 3,000 shares at 75.804CHF and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

9h / 37m 9h / 37m 1 EN
 PRESS RELEASE
Free
GALE GALENICA AG

Expansion of the Executive Committee and handover of the position of C...

Galenica AG / Key word(s): Strategic Company Decision Expansion of the Executive Committee and handover of the position of CFO 06.08.2024 / 07:00 CET/CEST Press release Galenica is aligning its pharmacy business to an even greater focus on customers. With Stephan Mignot, Marketing for the pharmacies will have a direct seat on the Executive Committee. In addition, the two strategic growth areas “Products & Brands” and “Home Care” are being merged into a single unit under the management of Thomas Szuran for focused expansion. The changes will enter into force on 1 September 2024. Th...

August 6, 2024 1 EN
 PRESS RELEASE
Free
GALE GALENICA AG

Élargissement de la Direction et passage de témoin au poste de CFO

Galenica AG / Mot-clé(s) : Décision stratégique d’entreprise Élargissement de la Direction et passage de témoin au poste de CFO 06.08.2024 / 07:00 CET/CEST Communiqué de presse Galenica recentre l’activité de ses pharmacies sur une approche plus orientée client; le marketing pour les pharmacies fait son entrée au sein de la Direction en la personne de Stephan Mignot; dans le cadre d’une stratégie de croissance ciblée, les deux secteurs clés «Products & Brands» et «Home Care» vont être fusionnés en une seule unité, placée sous la direction de Thomas Szuran. Autant de nouveautés qui ...

August 6, 2024 1 FR
 PRESS RELEASE
Free
GALE GALENICA AG

Erweiterung der Geschäftsleitung und Stabsübergabe auf der CFO-Positio...

Galenica AG / Schlagwort(e): Strategische Unternehmensentscheidung Erweiterung der Geschäftsleitung und Stabsübergabe auf der CFO-Position 06.08.2024 / 07:00 CET/CEST Medienmitteilung Die Galenica richtet ihr Apothekengeschäft auf noch mehr Kundenorientierung aus. Mit Stephan Mignot erhält das Marketing für die Apotheken direkten Einsitz in die Geschäftsleitung. Im Weiteren werden für den fokussierten Ausbau die beiden strategischen Wachstumsfelder «Products & Brands» sowie «Home Care» in einer Einheit unter der Leitung von Thomas Szuran zusammengefasst. Die Neuerungen treten per 1...

August 6, 2024 1 DE
 PRESS RELEASE
Free
GALE GALENICA AG

Galenica increases shareholding in Redcare Pharmacy to 10%

Galenica AG / Key word(s): Investment Galenica increases shareholding in Redcare Pharmacy to 10% 22.07.2024 / 18:11 CET/CEST Press release Today, Galenica notified the Dutch Authority for the Financial Markets (AFM) of its 10% stake in Redcare Pharmacy N.V. As part of the strategic partnership between Galenica and Redcare Pharmacy through the establishment of the joint venture Mediservice, Galenica has held a 7.9% stake in Redcare Pharmacy since May 2023. By increasing its participation, Galenica is strengthening its cooperation with Redcare Pharmacy, which has developed positively...

July 22, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch